Insel Gruppe Ag, University Hospital Bern
Clinical trials sponsored by Insel Gruppe Ag, University Hospital Bern, explained in plain language.
-
Chewing gum for weight loss in kids? study ends early
Disease control TerminatedThis study tested whether a special chewing gum with fiber could help obese children lose weight and improve their metabolism. About 93 children were enrolled, but the study was stopped early. The goal was to see changes in body mass index and blood sugar levels.
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Kidney nerve zapping fails to prove benefit for stubborn AFib
Disease control TerminatedThis study tested a procedure called renal denervation, which uses energy to calm kidney nerves, in 6 adults with recurrent atrial fibrillation (irregular heartbeat) despite prior successful lung-vein isolation. The goal was to see if it could reduce the amount of time spent in a…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Painkiller combo questioned: is extra paracetamol needed?
Symptom relief TerminatedThis study looked at whether cancer patients already taking strong opioids (like morphine) can stop taking paracetamol without their pain getting worse. Only 7 people took part before the study was stopped early. The goal was to see if paracetamol adds any extra benefit for pain …
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
Could a tailored Check-Up schedule improve life after head and neck cancer?
Knowledge-focused TerminatedThis study aimed to find the best way to monitor patients after they finish treatment for head and neck cancer. Researchers compared a personalized follow-up schedule, based on each patient's needs, to the usual one-size-fits-all approach. The goal was to see if a tailored plan c…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated May 26, 2026 06:07 UTC
-
Blood markers may predict dangerous MS relapses after drug stop
Knowledge-focused TerminatedThis study looked at whether certain markers on immune cells in the blood can predict if multiple sclerosis (MS) will become active again after stopping the drug ozanimod. Researchers planned to follow 23 adults with MS, measuring these markers before and after starting or stoppi…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated May 26, 2026 06:01 UTC
-
Spinal zap fails to prove benefit for brain bleed complication
Knowledge-focused TerminatedThis study tested whether electrical stimulation of the spinal cord could help widen narrowed brain arteries after a serious type of stroke called subarachnoid hemorrhage. Only one person was enrolled before the study was stopped early, so no clear conclusions can be drawn. The g…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC